Millan MJ

References (5)

Title : Dual-acting agents for improving cognition and real-world function in Alzheimer's disease: Focus on 5-HT6 and D3 receptors as hubs - Millan_2020_Neuropharmacol__108099
Author(s) : Millan MJ , Dekeyne A , Gobert A , Brocco M , Mannoury la Cour C , Ortuno JC , Watson D , Fone KCF
Ref : Neuropharmacology , :108099 , 2020
Abstract :
PubMedSearch : Millan_2020_Neuropharmacol__108099
PubMedID: 32525060

Title : Nicotine-induced structural plasticity in mesencephalic dopaminergic neurons is mediated by dopamine D3 receptors and Akt-mTORC1 signaling - Collo_2013_Mol.Pharmacol_83_1176
Author(s) : Collo G , Bono F , Cavalleri L , Plebani L , Mitola S , Merlo Pich E , Millan MJ , Zoli M , Maskos U , Spano P , Missale C
Ref : Molecular Pharmacology , 83 :1176 , 2013
Abstract :
PubMedSearch : Collo_2013_Mol.Pharmacol_83_1176
PubMedID: 23543412

Title : Activation of dopamine D1 receptors enhances cholinergic transmission and social cognition: a parallel dialysis and behavioural study in rats - Di Cara_2007_Int.J.Neuropsychopharmacol_10_383
Author(s) : Di Cara B , Panayi F , Gobert A , Dekeyne A , Sicard D , De Groote L , Millan MJ
Ref : Int J Neuropsychopharmacol , 10 :383 , 2007
Abstract :
PubMedSearch : Di Cara_2007_Int.J.Neuropsychopharmacol_10_383
PubMedID: 16925890

Title : The serotonin1A receptor partial agonist S15535 [4-(benzodioxan-5-yl)1-(indan-2-yl)piperazine] enhances cholinergic transmission and cognitive function in rodents: a combined neurochemical and behavioral analysis - Millan_2004_J.Pharmacol.Exp.Ther_311_190
Author(s) : Millan MJ , Gobert A , Roux S , Porsolt R , Meneses A , Carli M , Di Cara B , Jaffard R , Rivet JM , Lestage P , Mocaer E , Peglion JL , Dekeyne A
Ref : Journal of Pharmacology & Experimental Therapeutics , 311 :190 , 2004
Abstract :
PubMedSearch : Millan_2004_J.Pharmacol.Exp.Ther_311_190
PubMedID: 15146031

Title : Piribedil Enhances Frontocortical and Hippocampal Release of Acetylcholine in Freely Moving Rats by Blockade of alpha(2A)-Adrenoceptors: A Dialysis Comparison to Talipexole and Quinelorane in the Absence of Acetylcholinesterase Inhibitors - Gobert_2003_J.Pharmacol.Exp.Ther_305_338
Author(s) : Gobert A , Di Cara B , Cistarelli L , Millan MJ
Ref : Journal of Pharmacology & Experimental Therapeutics , 305 :338 , 2003
Abstract :
PubMedSearch : Gobert_2003_J.Pharmacol.Exp.Ther_305_338
PubMedID: 12649387